Although attenuation of insulin resistance by GLP-1 or AC3174 may contribute to this benefit, insulin-independent cardiac or extra-cardiac actions such as vasodilatation, renoprotection, and reduction of apoptosis [2,59-61] may have also contributed to the reduction in mortality. The gene discussed is GCG; the disease is Insulin resistance.